FDA Adverse Event Other Summary report: N

OSTEOSELECT DBM PUTTY

MDR report key: 3772098 · Received April 3, 2014

Report

Report Number
3005168462-2014-00008
Event Type
Other
Date Received
April 3, 2014
Date of Event
December 23, 2013
Report Date
April 2, 2014
Manufacturer
BACTERIN INTERNATIONAL, INC.
Product Code
MQV
PMA / PMN Number
K091321
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

ADD'L DEVICE MANUFACTURE DATE: 11/2012.

Description of Event or Problem · 1

BACTERIN WAS NOTIFIED ON (B)(6) 2014 OF 19 CASES PERFORMED BY A SURGEON THAT RESULTED IN POST-OP SEROMA FORMATION. BACTERIN PRODUCTS, OSTEOSPONGE AND/OR OSTEOSELECT DBM PUTTY HAD BEEN USED IN 10 OF THE 19 CASES. THE CASES OCCURRED AT TWO FACILITIES. ONE OF THESE FACILITIES IS INVESTIGATING THE HIGH RATE OF I&D ADMITS FOR THIS SURGEON. IT WAS NOTED BY THE INITIAL RPTR THAT THE PHYSICIAN USES A CLOSURE TECHNIQUE THAT ALLOWS "DEAD SPACE" WHICH MAY FACILITATE SEROMA FORMATION. THIS SURGEON HAS PREVIOUSLY REPORTED POST OP SEROMA FORMATION USING BACTERIN PRODUCTS. HISTORICAL EVALUATIONS OF POTENTIAL ADVERSE REACTIONS REPORTS REC'D BY BACTERIN SINCE (B)(6) 2011 (INCLUDING THESE 10 RECENTLY REC'D) SHOW THAT THIS PHYSICIAN WAS INVOLVED IN 68% OF THE CASES. BACTERIN HAS NOT REC'D ANY OTHER REPORTS OF POTENTIAL ADVERSE REACTIONS RESULTING FROM THE USE OF OSTEOSPONGE PRODUCTS. ALL BACTERIN PRODUCTS ARE PROVIDED STERILE VIA EXPOSURE TO A VALIDATED GAMMA IRRADIATION DOSE IN THE FINAL PACKAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
203045 OSTEOSELECT DBM PUTTY MQV, MBP MQV BACTERIN INTERNATIONAL, INC. 309100 B120305-DBM

Patients

Seq Age Sex Outcome Treatment
1 51 YR Other 309100, B120332-DBM, B120332-706: EXP 11/14/2014| OSTEOSPONGE FILLER 10.0CC: LOT # B130343-OST,| OSTEOSPONGE FILLER 10.0CC: LOT # B120496-OST| EXP DATE 11/18/2018, B130343-245| EXP DATE 03/13/2018, B120496-233